Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease

Journal of Neuroscience

Volumn 27, Issue 30, 2007, Pages 8011-8022

  Carlsson, Thomas ^a   Carta, Manolo ^a   Winkler, Christian ^b   Björklund, Anders ^a   Kirik, Deniz ^a,c  

^a LUND UNIVERSITY   (Sweden)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c LUND UNIVERSITY   (Sweden)

Author keywords

5 hydroxytryptamine; 6 hydroxydopamine; Cell grafting; Dopamine; Levodopa; Ventral mesenchephalon

Indexed keywords

LEVODOPA; OXIDOPAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; CONVALESCENCE; DISEASE EXACERBATION; DOPAMINERGIC NERVE CELL; DYSKINESIA; EXPERIMENTAL MODEL; FEMALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL;

ANIMALS; BRAIN TISSUE TRANSPLANTATION; DISEASE MODELS, ANIMAL; DYSKINESIA, DRUG-INDUCED; FEMALE; FETAL TISSUE TRANSPLANTATION; LEVODOPA; NEURONS; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN;

EID: 34547484764     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2079-07.2007     Document Type: Article

References (43)

1. Arai R, Karasawa N, Geffard M, Nagatsu T, Nagatsu I (1994) Immunohistochemical evidence that central serotonin neurons produce dopamine from exogenous L-DOPA in the rat, with reference to the involvement of aromatic L-amino acid decarboxylase. Brain Res 667:295-299.
2. Arai R, Karasawa N, Geffard M, Nagatsu I (1995) L-DOPA is converted to dopamine in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study. Neurosci Lett 195:195-198.
3. 1A receptor in cortex and dentate gyrus display exaggerated locomotor and hypothermic response to 8-OHDPAT. Behav Brain Res 167:328-341.
4. Bjorklund A (1992) Dopaminergic transplants in experimental parkinsonism: cellular mechanisms of graft-induced functional recovery. Curr Opin Neurobiol 2:683-689.
5. Brown LL, Sharp FR (1995) Metabolic mapping of rat striatum: somatotopic organization of sensorimotor activity. Brain Res 686:207-222.
6. Brundin P, Duan WM, Sauer H (1994) Functional effects of mesencephalic dopamine and adrenal chromaffin cells grafted to the rodent striatum. In: Functional neural transplantation (Dunnett SB, Bjorklund A, eds), pp 9-46. New York: Raven.
7. Brundin P, Pogarell O, Hagell P, Piccini P, Widner H, Schrag A, Kupsch A, Crabb L, Odin P, Gustavii B, Bjorklund A, Brooks DJ, Marsden CD, Oertel WH, Quinn NP, Rehncrona S, Lindvall O (2000) Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 123:1380-1390.
8. Canales JJ, Gilmour G, Iversen SD (2000) The role of nigral and thalamic output pathways in the expression of oral stereotypies induced by amphetamine injections into the striatum. Brain Res 856:176-183.
9. Carey RJ, Depalma G, Damianopoulos E, Muller CP, Huston JP (2004) The 5-HT1A receptor and behavioral stimulation in the rat: effects of 8-OHDPAT on spontaneous and cocaine-induced behavior. Psychopharmacology (Berl) 177:46-54.
10. Carlsson T, Winkler C, Lundblad M, Cenci MA, Bjorklund A, Kirik D (2006) Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia. Neurobiol Dis 21:657-668.
11. Carta M, Carlsson T, Kirik D, Bjorklund A (2007) Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. Brain 130:1819-1833.
12. De Deurwaerdere P, Navailles S, Berg KA, Clarke WP, Spampinato U (2004) Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens. J Neurosci 24:3235-3241.
13. Defer GL, Geny C, Ricolfi F, Fenelon G, Monfort JC, Remy P, Villafane G, Jeny R, Samson Y, Keravel Y, Gaston A, Degos JD, Peschanski M, Cesaro P, Nguyen JP (1996) Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach. Brain 119:41-50.
14. Dunnett SB, Bjorklund A (1992) Neural transplantation: a practical approach. Oxford: Oxford UP.
15. Dunnett SB, Bjorklund A, Stenevi U, Iversen SD (1981) Grafts of embryonic substantia nigra reinnervating the ventrolateral striatum ameliorate sensorimotor impairments and akinesia in rats with 6-OHDA lesions of the nigrostriatal pathway. Brain Res 229:209-217.
16. Dunnett SB, Bjorklund A, Schmidt RH, Stenevi U, Iversen SD (1983) Intracerebral grafting of neuronal cell suspensions. IV. Behavioural recovery in rats with unilateral 6-OHDA lesions following implantation of nigral cell suspensions in different forebrain sites. Acta Physiol Scand Suppl 522:29-37.
17. Forni C, Brundin P, Strecker RE, el Ganouni S, Bjorklund A, Nieoullon A (1989) Time-course of recovery of dopamine neuron activity during re-innervation of the denervated striatum by fetal mesencephalic grafts as assessed by in vivo voltammetry. Exp Brain Res 76:75-87.
18. Georgievska B, Carlsson T, Lacar B, Winkler C, Kirik D (2004) Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor. Eur J Neurosci 20:3121-3130.
19. Gundersen HJ, Jensen EB (1987) The efficiency of systematic sampling in stereology and its prediction. J Microsc 147:229-263.
20. Hagell P, Schrag A, Piccini P, Jahanshahi M, Brown R, Rehncrona S, Widner H, Brundin P, Rothwell JC, Odin P, Wenning GK, Morrish P, Gustavii B, Bjorklund A, Brooks DJ, Marsden CD, Quinn NP, Lindvall O (1999) Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain 122:1121-1132.
21. Hauser RA, Freeman TB, Snow BJ, Nauert M, Gauger L, Kordower JH, Olanow CW (1999) Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch Neurol 56:179-187.
22. Hollister AS, Breese GR, Mueller RA (1979) Role of monoamine neural systems in L-dihydroxyphenylalanine-stimulated activity. J Pharmacol Exp Ther 208:37-43.
23. Kelley AE, Lang CG, Gauthier AM (1988) Induction of oral stereotypy following amphetamine microinjection into a discrete subregion of the striatum. Psychopharmacology (Berl) 95:556-559.
24. Kirik D, Winkler C, Bjorklund A (2001) Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration. J Neurosci 21:2889-2896.
25. Lane EL, Winkler C, Brundin P, Cenci MA (2006) The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat. Neurobiol Dis 22:334-345.
26. Lee CS, Cenci MA, Schulzer M, Bjorklund A (2000) Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease. Brain 123:1365-1379.
27. Lindgren HS, Rylander D, Ohlin KE, Lundblad M, Cenci MA (2007) The "motor complication syndrome" in rats with 6-OHDA lesions treated chronically with L-DOPA: Relation to dose and route of administration. Behav Brain Res 177:150-159.
28. Maeda T, Nagata K, Yoshida Y, Kannari K (2005) Serotonergic hyperinnervation into the dopaminergic denervated striatum compensates for dopamine conversion from exogenously administered L-DOPA. Brain Res 1046:230-233.
29. Mandel RJ, Brundin P, Bjorklund A (1990) The importance of graft placement and task complexity for transplant-induced recovery of simple and complex sensorimotor deficits in dopamine denervated rats. Eur J Neurosci 2:888-894.
30. Ng KY, Chase TN, Colburn RW, Kopin IJ (1970) L-DOPA-induced release of cerebral monoamines. Science 170:76-77.
31. Ng KY, Colburn RW, Kopin IJ (1971) Effects of L-DOPA on efflux of cerebral monoamines from synaptosomes. Nature 230:331-332.
32. Nikkhah G, Olsson M, Eberhard J, Bentlage C, Cunningham MG, Bjorklund A (1994) A microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology. Neuroscience 63:57-72.
33. Paxinos G, Watson C (2005) The rat brain in stereotaxic coordinates, Ed 5. San Diego: Academic.
34. Rodriguez-Pallares J, Guerra MJ, Labandeira-Garcia JL (2003) Elimination of serotonergic cells induces a marked increase in generation of dopaminergic neurons from mesencephalic precursors. Eur J Neurosci 18:2166-2174.
35. Schallert T, Tillerson J (1999) Intervention strategies for degeneration of dopamine neurons in parkinsonism: optimising behavioral assessment of outcome. In: Innovative models of CNS disease: from molecule to therapy, pp 131-151. Clifton, NJ: Humana.
36. Sprouse JS, Aghajanian GK (1987) Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse 1:3-9.
37. Stromberg I, Kehr J, Andbjer B, Fuxe K (2000) Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum. Exp Neurol 164:154-165.
38. Torres EM, Meldrum A, Kirik D, Dunnett SB (2006) An investigation of the problem of two-layered immunohistochemical staining in paraformaldehyde fixed sections. J Neurosci Methods 158:64-74.
39. West MJ (1999) Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends Neurosci 22:51-61.
40. Widner H, Tetrud J, Rehncrona S, Snow B, Brundin P, Gustavii B, Bjorklund A, Lindvall O, Langston JW (1992) Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP). N Engl J Med 327:1556-1563.
41. Winkler C, Bentlage C, Nikkhah G, Samii M, Bjorklund A (1999) Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants. Exp Neurol 155:165-186.
42. Winkler C, Kirik D, Bjorklund A, Cenci MA (2002) L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of Parkinson's disease: relation to motor and cellular parameters of nigrostriatal function. Neurobiol Dis 10:165-186.
43. Winkler C, Kirik D, Bjorklund A (2005) Cell transplantation in Parkinson's disease: how can we make it work? Trends Neurosci 28:86-92.